{
    "nct_id": "NCT03138967",
    "official_title": "A Phase IV Investigation of Sugammadex in Outpatient Urological Procedures",
    "inclusion_criteria": "1. Is scheduled to undergo cystoscopy with bladder resection procedure under general anesthesia requiring neuromuscular relaxation using rocuronium bromide to secure airway and requiring neuromuscular reversal at The University of Texas MD Anderson Cancer Center - Mays Clinic (ACB-outpatient)\n2. Male or Females who are >= 18 years of age\n3. Classified by the American Society of Anesthesiologists (ASA) as Class I - IV\n4. Candidate for use of laryngeal mask airway (LMA)\n5. Able to give consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Severe renal impairment as measured eGFR less than 30 per institutional laboratory.\n2. Females who are pregnant or might be pregnant or are breast-feeding.\n3. Females who have been diagnosed with breast cancer and currently taking Toremifene\n4. Is known or suspected to have significant hepatic dysfunction, with AST & ALT 3 times above UNL per institutional laboratory.\n5. Is known or suspected to have a (family) history of malignant hyperthermia\n6. Is known or suspected to have an allergy to opioids, muscle relaxants or other medications used during general anesthesia\n7. Is known or suspected to have neuromuscular disorders (ex: myasthenia gravis)",
    "miscellaneous_criteria": ""
}